62 related articles for article (PubMed ID: 15916209)
1. Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing.
Knesel BW; Dry JC; Wald-Scott C; Aftab A
J Reprod Med; 2005 Apr; 50(4):256-60. PubMed ID: 15916209
[TBL] [Abstract][Full Text] [Related]
2. Self-sampling versus physician-sampling for human papillomavirus testing.
Agorastos T; Dinas K; Lloveras B; Font R; Kornegay JR; Bontis J; de Sanjose S
Int J STD AIDS; 2005 Nov; 16(11):727-9. PubMed ID: 16303065
[TBL] [Abstract][Full Text] [Related]
3. Liquid-based cytology for cervical cancer screening.
Bentz JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
[TBL] [Abstract][Full Text] [Related]
4. Women in the Netherlands prefer self-sampling with a novel lavaging device to clinician collection of specimens for cervical cancer screening.
Jones HE; Wiegerinck MA; Nieboer TE; Mol BW; Westhoff CL
Sex Transm Dis; 2008 Nov; 35(11):916-7. PubMed ID: 18665020
[No Abstract] [Full Text] [Related]
5. Self-test device for cytology and HPV testing in rural Appalachian women: an evaluation.
Soisson AP; Reed E; Brown P; Ducatman B; Armistead J; Kennedy S; Wang W; Kramer P; Rose S
J Reprod Med; 2008 Jun; 53(6):441-8. PubMed ID: 18664063
[TBL] [Abstract][Full Text] [Related]
6. Chlamydia/gonorrhea combo and HR HPV DNA testing in liquid-based pap.
Hawthorne CM; Farber PJ; Bibbo M
Diagn Cytopathol; 2005 Sep; 33(3):177-80. PubMed ID: 16078250
[TBL] [Abstract][Full Text] [Related]
7. Acceptability of self-collection of specimens for HPV DNA testing in an urban population.
Anhang R; Nelson JA; Telerant R; Chiasson MA; Wright TC
J Womens Health (Larchmt); 2005 Oct; 14(8):721-8. PubMed ID: 16232104
[TBL] [Abstract][Full Text] [Related]
8. Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women.
De Alba I; Anton-Culver H; Hubbell FA; Ziogas A; Hess JR; Bracho A; Arias C; Manetta A
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2163-8. PubMed ID: 18708409
[TBL] [Abstract][Full Text] [Related]
9. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
10. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based pap test samples taken with different collection devices.
Chernesky M; Jang D; Smieja M; Portillo E; Ewert R; Pritchard C; MacEachern D; Doucette C; MacDonald A; Kapala J; Sumner J; Hill C
Sex Transm Dis; 2009 Sep; 36(9):581-3. PubMed ID: 19661842
[TBL] [Abstract][Full Text] [Related]
11. Discussions about self-obtained samples for HPV testing as an alternative for cervical cancer prevention.
Barata PC; Mai V; Howlett R; Gagliardi AR; Stewart DE
J Psychosom Obstet Gynaecol; 2008 Dec; 29(4):251-7. PubMed ID: 18608824
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
[TBL] [Abstract][Full Text] [Related]
13. Anal human papillomavirus testing with Digene's hybrid capture 2 using two different sampling methods.
Roka F; Roka J; Trost A; Schalk H; Zagler C; Kirnbauer R; Salat A
Dis Colon Rectum; 2008 Jan; 51(1):62-6. PubMed ID: 18030530
[TBL] [Abstract][Full Text] [Related]
14. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
15. Liquid based cytology: examination of its potential in a chlamydia screening programme.
Hopwood J; Mallinson H; Hodgson E; Hull L
Sex Transm Infect; 2004 Oct; 80(5):371-3. PubMed ID: 15459404
[TBL] [Abstract][Full Text] [Related]
16. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.
Smith-McCune KK; Tuveson JL; Rubin MM; Da Costa MM; Darragh TM; Shiboski SC; Van Der Pol B; Moscicki AB; Palefsky JM; Sawaya GF
J Low Genit Tract Dis; 2006 Oct; 10(4):213-8. PubMed ID: 17012985
[TBL] [Abstract][Full Text] [Related]
17. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
18. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
19. Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery.
Habis AH; Vernon SD; Lee DR; Verma M; Unger ER
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):492-6. PubMed ID: 15006929
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
Bidus MA; Maxwell GL; Kulasingam S; Rose GS; Elkas JC; Chernofsky M; Myers ER
Obstet Gynecol; 2006 May; 107(5):997-1005. PubMed ID: 16648402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
